At 95, Buffett is still sharpest dealmaker with  billion OxyChem deal

At 95, Buffett is still sharpest dealmaker with $10 billion OxyChem deal

Warren Buffett’s shrewd dealmaking instincts remain intact even as the 95-year-old legendary investor inches close to the end of his term as Berkshire Hathaway CEO. Berkshire said Thursday it reached a deal to buy Occidental Petroleum’s chemical business, OxyChem, for $9.7 billion in cash, marking its largest purchase since 2022. The transaction reflects Buffett’s investment…

Read More
Two AI-adjacent stocks investor Kevin Simpson snapped up amid the volatility

Two AI-adjacent stocks investor Kevin Simpson snapped up amid the volatility

Investor Kevin Simpson found opportunities amid the market volatility this week. The founder and CEO of Capital Wealth Planning snapped up two non-tech names that he said could benefit from the artificial-intelligence buildout. They are among the opportunities he sees outside of the “Magnificent Seven” for his firm’s growth strategy. Simpson bought Eagle Materials ,…

Read More